| (+)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein] | CTD | PMID:21535577 |
| (+)-alpha-tocopherol | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:19595682 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:20024955 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCAT mRNA | CTD | PMID:18465118 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10859 | 6480464 | Tetrachlorodibenzodioxin affects the expression of LCAT mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10859 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCAT mRNA | CTD | PMID:19770486 PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10859 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCAT mRNA | CTD | PMID:18796159 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10859 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LCAT mRNA | CTD | PMID:18796159 |
| 26-hydroxycholesterol | increases metabolic processing | ISO | RGD:737383 | 6480464 | LCAT protein results in increased metabolism of 27-hydroxycholesterol | CTD | PMID:7744831 |
| 3-methylcholanthrene | decreases expression | EXP | | 6480464 | Methylcholanthrene results in decreased expression of LCAT mRNA | CTD | PMID:11328961 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:737383 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of LCAT mRNA | CTD | PMID:12419474 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| aflatoxin B1 | decreases expression | ISO | RGD:10859 | 6480464 | Aflatoxin B1 results in decreased expression of LCAT mRNA | CTD | PMID:19770486 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of LCAT mRNA | CTD | PMID:16483693 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10859 | 6480464 | Benzo(a)pyrene results in decreased expression of LCAT mRNA | CTD | PMID:19770486 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:10859 | 6480464 | Mustard Gas results in increased expression of LCAT mRNA | CTD | PMID:15674843 |
| cadmium atom | decreases activity | EXP | | 6480464 | Cadmium results in decreased activity of LCAT protein | CTD | PMID:21535577 |
| cadmium atom | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein] | CTD | PMID:21535577 |
| chlorogenic acid | multiple interactions | EXP | | 6480464 | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein]; more ... | CTD | PMID:20696151 |
| cholesterol | increases acylation | ISO | RGD:737383 | 6480464 | LCAT protein results in increased acylation of Cholesterol | CTD | PMID:4847537 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of LCAT mRNA | CTD | PMID:11328961 |
| clofibrate | multiple interactions | ISO | RGD:10859 | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LCAT mRNA] | CTD | PMID:17585979 |
| clofibrate | decreases expression | ISO | RGD:10859 | 6480464 | Clofibrate results in decreased expression of LCAT mRNA | CTD | PMID:17585979 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of LCAT mRNA | CTD | PMID:17602206 |
| copper atom | decreases activity | ISO | RGD:737383 | 6480464 | Copper results in decreased activity of LCAT protein | CTD | PMID:7751820 |
| copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of LCAT mRNA | CTD | PMID:19821111 |
| copper(0) | decreases activity | ISO | RGD:737383 | 6480464 | Copper results in decreased activity of LCAT protein | CTD | PMID:7751820 |
| copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of LCAT mRNA | CTD | PMID:19821111 |
| copper(2+) sulfate | decreases expression | ISO | RGD:737383 | 6480464 | Copper Sulfate results in decreased expression of LCAT mRNA | CTD | PMID:19549813 |
| copper(II) chloride | increases expression | ISO | RGD:10859 | 6480464 | cupric chloride results in increased expression of LCAT mRNA | CTD | PMID:17211630 |
| diazoxide | multiple interactions | EXP | | 6480464 | alliin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:16640830 |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:15740881 more ... |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:15740881 more ... |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:19595682 more ... |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:16640830 more ... |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:16906524 more ... |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:16906524 more ... |
| diazoxide | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:19595682 |
| diazoxide | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:15740881 more ... |
| diazoxide | multiple interactions | EXP | | 6480464 | naringin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:16906524 |
| diazoxide | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:20024955 |
| diazoxide | multiple interactions | EXP | | 6480464 | Desmodium gangeticum extract inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:15740881 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of LCAT mRNA | CTD | PMID:18636392 |
| dichlorine | decreases expression | EXP | | 6480464 | Chlorine results in decreased expression of LCAT mRNA | CTD | PMID:18636392 |
| dichlorvos | decreases activity | ISO | RGD:737383 | 6480464 | Dichlorvos results in decreased activity of LCAT protein | CTD | PMID:4847537 |
| dichlorvos | multiple interactions | ISO | RGD:737383 | 6480464 | Dichlorvos inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] | CTD | PMID:4847537 |
| dioleoyl phosphatidylcholine | affects binding | ISO | RGD:737383 | 6480464 | LCAT protein binds to 1,2-oleoylphosphatidylcholine | CTD | PMID:16780378 |
| fenitrothion | multiple interactions | ISO | RGD:737383 | 6480464 | Fenitrothion inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] | CTD | PMID:4847537 |
| fenitrothion | decreases activity | ISO | RGD:737383 | 6480464 | Fenitrothion results in decreased activity of LCAT protein | CTD | PMID:4847537 |
| fumonisin B1 | decreases expression | ISO | RGD:10859 | 6480464 | fumonisin B1 results in decreased expression of LCAT mRNA | CTD | PMID:16221962 |
| furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of LCAT mRNA | CTD | PMID:15120968 |
| hydrogen peroxide | decreases expression | ISO | RGD:737383 | 6480464 | Hydrogen Peroxide results in decreased expression of LCAT mRNA | CTD | PMID:12419474 |
| isoprenaline | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:19595682 |
| isoprenaline | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:15740881 more ... |
| isoprenaline | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:15740881 more ... |
| isoprenaline | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:19595682 more ... |
| isoprenaline | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:16640830 more ... |
| isoprenaline | multiple interactions | EXP | | 6480464 | naringin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:16906524 |
| isoprenaline | decreases activity | EXP | | 6480464 | Isoproterenol results in decreased activity of LCAT protein | CTD | PMID:16906524 more ... |
| isoprenaline | multiple interactions | EXP | | 6480464 | Desmodium gangeticum extract inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:15740881 |
| isoprenaline | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:20024955 |
| isoprenaline | multiple interactions | EXP | | 6480464 | alliin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:16640830 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| lithocholic acid | decreases expression | ISO | RGD:10859 | 6480464 | Lithocholic Acid results in decreased expression of LCAT mRNA | CTD | PMID:20359477 |
| lithocholic acid | multiple interactions | ISO | RGD:10859 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of LCAT mRNA | CTD | PMID:20359477 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of LCAT mRNA | CTD | PMID:19638242 |
| naringin | multiple interactions | EXP | | 6480464 | naringin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:16906524 |
| nevirapine | increases expression | ISO | RGD:737383 | 6480464 | Nevirapine results in increased expression of LCAT protein | CTD | PMID:19667106 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein]; more ... | CTD | PMID:20696151 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] affects the expression of LCAT mRNA | CTD | PMID:18636392 |
| paracetamol | multiple interactions | ISO | RGD:10859 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of LCAT mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:737383 | 6480464 | Acetaminophen results in increased expression of LCAT mRNA | CTD | PMID:21420995 |
| parathion-methyl | decreases activity | ISO | RGD:737383 | 6480464 | Methyl Parathion results in decreased activity of LCAT protein | CTD | PMID:4847537 |
| parathion-methyl | multiple interactions | ISO | RGD:737383 | 6480464 | Methyl Parathion inhibits the reaction [[LCAT protein results in increased metabolism of Lecithins] which results in increased chemical synthesis of Cholesterol Esters] | CTD | PMID:4847537 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:10859 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of LCAT mRNA | CTD | PMID:21705711 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:10859 | 6480464 | perfluorooctanoic acid results in decreased expression of LCAT mRNA | CTD | PMID:17681415 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of LCAT mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of LCAT mRNA | CTD | PMID:19162173 |
| phenytoin | increases expression | ISO | RGD:10859 | 6480464 | Phenytoin results in increased expression of LCAT mRNA | CTD | PMID:15136057 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of LCAT mRNA | CTD | PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of LCAT mRNA | CTD | PMID:16940010 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:10859 | 6480464 | [Lithocholic Acid co-treated with Pregnenolone Carbonitrile] results in decreased expression of LCAT mRNA | CTD | PMID:20359477 |
| quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] | CTD | PMID:19595682 |
| quercetin | affects expression | ISO | RGD:737383 | 6480464 | Quercetin affects the expression of LCAT mRNA | CTD | PMID:21632981 |
| quercetin | multiple interactions | EXP | | 6480464 | [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein] | CTD | PMID:21535577 |
| resveratrol | decreases expression | ISO | RGD:10859 | 6480464 | resveratrol results in decreased expression of LCAT mRNA | CTD | PMID:19028542 |
| simvastatin | increases activity | ISO | RGD:10859 | 6480464 | Simvastatin results in increased activity of LCAT protein | CTD | PMID:21241519 |
| streptozocin | multiple interactions | EXP | | 6480464 | Chlorogenic Acid results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein]; more ... | CTD | PMID:20696151 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:737383 | 6480464 | tert-Butylhydroperoxide results in decreased expression of LCAT mRNA | CTD | PMID:12419474 |
| tetrahydrocurcumin | multiple interactions | EXP | | 6480464 | tetrahydrocurcumin results in decreased susceptibility to [[Streptozocin co-treated with Niacinamide] results in decreased activity of LCAT protein]; more ... | CTD | PMID:20696151 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of LCAT mRNA | CTD | PMID:19483382 |
| trans-resveratrol | decreases expression | ISO | RGD:10859 | 6480464 | resveratrol results in decreased expression of LCAT mRNA | CTD | PMID:19028542 |
| valproic acid | affects expression | ISO | RGD:10859 | 6480464 | Valproic Acid affects the expression of LCAT mRNA | CTD | PMID:17292431 |
| zinc atom | affects expression | EXP | | 6480464 | Zinc affects the expression of LCAT mRNA | CTD | PMID:16413754 |
| zinc(0) | affects expression | EXP | | 6480464 | Zinc affects the expression of LCAT mRNA | CTD | PMID:16413754 |